Trade XWELL, Inc - XWEL CFD

XpresSpa Group Inc. (XSPA) is a global travel health and wellness services provider. It operates three business segments: XpresSpa, XpressTest, and Treat. 

A global airport provider of spa services, XpresSpa offers travelers premium spa, including massage, nail and skin care, as well as spa and travel products. In March 2020, the company temporarily closed all its global XpresSpa locations amid travel restrictions caused by the global pandemic. It reopened 22 XpresSpa locations as of 31 December 2021.

XpresTest provides Covid-19 and other medical diagnostic testing services to travellers, as well as airline, airport, and concessionaire personnel, Transportation Security Administration (TSA), and US Customs and Border Protection agents.

Treat, Inc., the New York-based company's third subsidiary, was formed in 2021 and delivers health and wellness services to travellers via an integrated digital platform and a related retail offering. As of June 2022, Treat operates three on-site locations: JFK International Airport, Phoenix Sky Harbor International Airport, and Salt Lake City International Airport, which is planned to launch in late 2022. 

Treat's on-site clinics offer virus, cold, flu, and other diagnostic testing, as well as hydration therapy, IV drips, and vitamin injections. Travelers can buy time blocks to use Treat's wellness rooms, which offer interactive activities such as self-guided yoga and meditation for relaxation. 

The company said it does not anticipate paying any cash dividends in the foreseeable future. 

Formerly known as FORM Holdings Corp, XpresSpa Group went public through an initial public offering (IPO) on 21 June 2010, at an offering price of $4.60 per share. The shares are traded on the NASDAQ under the ticker symbol XSPA.

Follow XpresSpa stock price at Capital.com. Stay on top of the latest XpresSpa Group share price developments with our live XSPA stock price chart.